Israeli drug Amor-18 has shown tremendous result in treating COVID patients. This medicine is developed by Israeli biotech company Amorphical.
Dr. Nashat Abu Saleh, co-director of the coronavirus department at Ziv Medical Center in Safed, where the phase II clinical trial was conducted said: “Since the patients treated with the drug recovered within a few days and were released to their home, this was 100 percent successful”.
Amor-18, which uses Amorphous Calcium Carbonate (ACC) as the main ingredient, was administered orally or by inhalation. As explained by the company, ACC has the ability to modulate acidic pH changes around each cell. These changes affect the capability of COVID-19 to penetrate the cells and replicate. This allows the drug to prevent the virus from spreading and thus the patients from deteriorating.
Yossi Ben, CEO, Amorphical said: “We are excited about the results of the clinical trial, which bring real hope to COVID-19 patients in Israel and around the world, and are especially encouraging these days with the start of the fifth wave of the Omicron variant The drug we have developed is anti-inflammatory, safe and effective and it is easy to use”.
Amorphical CEO noted that Amor-18 will work against the entire SARS virus family, including all COVID variants.
A larger trial is already being conducted at the Ziv, Shamir, Kaplan and Mayanei Hayeshua medical centers in Israel. Soon the drug will be tested in other countries. Seven hospitals in Brazil have announced that they will participate, and other centers in Europe and the United States are expected to join soon.
Meanwhile, some of the leading biotech research companies are already working on finding a perfect vaccine that can ensure 100 percent efficacy in fighting COVID and all types of variants. Once this vaccine is made available in the market, the entire world will get rid of the repeated hassles caused by COVID variants. It may be mentioned here that, leading vaccine manufacturers are touting a third and even a fourth vaccine jab, while some of these companies are indicating of “regular vaccination” for remaining safeguarded from the virus.
